(1'R,2R,2'S,3R,3aS,6S,7aR,10'S,11'R)-3,6,6',11'-tetramethylspiro[3a,4,5,6,7,7a-hexahydro-3H-furo[3,2-b]pyridine-2,5'-pentacyclo[8.8.0.02,8.06,8.011,16]octadec-15-ene]-14'-one | 878204-90-1

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 类固醇和类固醇衍生物
• 英文名称: (1'R,2R,2'S,3R,3aS,6S,7aR,10'S,11'R)-3,6,6',11'-tetramethylspiro[3a,4,5,6,7,7a-hexahydro-3H-furo[3,2-b]pyridine-2,5'-pentacyclo[8.8.0.02,8.06,8.011,16]octadec-15-ene]-14'-one
• CAS: 878204-90-1
• 化学式: C₂₈H₄₁NO₂
• 分子量: 423.639
• InChiKey: JLSYVOULHRUIEQ-WINXDUGXSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.8
• 重原子数：
  31
• 可旋转键数：
  0
• 环数：
  7.0
• sp3杂化的碳原子比例：
  0.89
• 拓扑面积：
  38.3
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (1'R,2R,2'S,3R,3aS,6S,7aR,10'S,11'R)-3,6,6',11'-tetramethylspiro[3a,4,5,6,7,7a-hexahydro-3H-furo[3,2-b]pyridine-2,5'-pentacyclo[8.8.0.02,8.06,8.011,16]octadec-15-ene]-14'-one 在 三氟化硼乙醚 作用下， 以 二氯甲烷 为溶剂， 反应 1.5h， 以90%的产率得到IPI-269609
  参考文献：
  名称：

  [EN] CYCLOPAMINE ANALOGUES AND METHODS OF USE THEREOF
  [FR] ANALOGUES DE CYCLOPAMINE ET PROCEDES D'UTILISATION DE CEUX-CI

  摘要：

  公开号：

  WO2006026430A3
• 作为产物：
  描述：

  cyclopamine-4-ene-3-one 在 diethylzinc 、 sodium hydroxide 作用下， 以 二氯甲烷 、 甲苯 、 水 为溶剂， 反应 3.25h， 生成 (1'R,2R,2'S,3R,3aS,6S,7aR,10'S,11'R)-3,6,6',11'-tetramethylspiro[3a,4,5,6,7,7a-hexahydro-3H-furo[3,2-b]pyridine-2,5'-pentacyclo[8.8.0.02,8.06,8.011,16]octadec-15-ene]-14'-one
  参考文献：
  名称：

  WO2007/123511

  摘要：

  公开号：

文献信息

• Cyclopamine analogues and methods of use thereof
  申请人：Infinity Pharmaceuticals, Inc.

  公开号：EP2316832A1

  公开（公告）日：2011-05-04

  The present invention provides compositions for use in modulating smoothened dependent pathway activation. The present invention provides analogs of cyclopamine of formulas that can be used to counteract the phenotypic effects of unwanted activation of a hedgehog pathway, such as resulting from hedgehog gain-of-function, Ptc loss-of-function or smoothened gain-of-function mutations. The compounds of the present invention are particularly useful in treating cancers.

  本发明提供了用于调节平滑依赖性通路活化的组合物。本发明提供了形式如下的环丙胺类似物 可用于抵消刺猬通路不需要的活化的表型效应，例如由刺猬功能增益、Ptc 功能缺失或平滑依赖功能增益突变引起的表型效应。本发明的化合物尤其适用于治疗癌症。
• Process for the preparation of Cyclopamine analogue compounds
  申请人：Infinity Pharmaceuticals, Inc.

  公开号：EP2316833A1

  公开（公告）日：2011-05-04

  The present invention provides a preparation method for analogs of cyclopamine of formula 1 that can be used to counteract the phenotypic effects of unwanted activation of a hedgehog pathway, such as resulting from hedgehog gain-of-function, Ptc loss-of-function or smoothened gain-of-function mutations. The compounds of the present invention are particularly useful in treating cancers.

  本发明提供了一种式 1 环胺类似物的制备方法 本发明提供了一种环丙胺类似物的制备方法，该类似物可用于抵消刺猬通路不需要的激活所产生的表型效应，例如刺猬功能增益突变、Ptc 功能缺失突变或平滑功能增益突变所导致的表型效应。 本发明的化合物尤其适用于治疗癌症。
• CYCLOPAMINE ANALOGUES AND METHODS OF USE THEREOF
  申请人：Infinity Pharmaceuticals, Inc.

  公开号：EP1817308B1

  公开（公告）日：2014-10-08
• DOSING REGIMENS FOR THE TREATMENT OF CANCER
  申请人：Mcgovern Karen J.

  公开号：US20110034498A1

  公开（公告）日：2011-02-10

  The invention relates to a method of treating cancer. The method includes administering systemically a therapeutically effective amount of a small molecule hedgehog pathway inhibitor, such that the concentration of the inhibitor in the blood does not vary by more than about ±30% from the average concentration, and such that the concentration remains at or below the maximum tolerated dose of the inhibitor for a time period of at least about one day.
• Cyclopamine Analogues and Methods of Use Thereof
  申请人：Adams Julian

  公开号：US20110166353A1

  公开（公告）日：2011-07-07

  The present invention provides compositions and methods for modulating smoothened-dependent pathway activation. The present invention provides analogs of cyclopamine that can be used to counteract the phenotypic effects of unwanted activation of a hedgehog pathway, such as resulting from hedgehog gain-of-function, Ptc loss-of-function or smoothened gain-of-function mutations. The compounds of the present invention are particularly useful in treating cancers.